CALMARE THERAPEUTICS Inc 4
4 · CALMARE THERAPEUTICS Inc · Filed May 19, 2015
Insider Transaction Report
Form 4
Brennan Peter F
Director
Transactions
- Award
Options
2015-01-02+10,000→ 2,419,981 totalExercise: $0.17From: 2015-01-02Exp: 2020-01-02→ Common stock, par value $0.01 per share (10,000 underlying) - Award
Common Stock
2015-01-02+2,500→ 1,368,615 total
Footnotes (2)
- [F1]Peter Brennan is the beneficial owner of Damel Diversified LP, Peter Brennan, LISL Brennan 2005 Family Trust, LISL Brennan, Peter Brennan IRA, Julia T Brennan and Julia T Brennan IRA.
- [F2]Includes 40,000 stock options and the right to acquire an additional 2,379,981 shares upon conversion of $2,498,980 of convertible debt.